pioglitazone has been researched along with African Lymphoma in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zang, C | 1 |
Liu, H | 1 |
Posch, MG | 1 |
Waechter, M | 1 |
Facklam, M | 1 |
Fenner, MH | 1 |
Ruthardt, M | 1 |
Possinger, K | 1 |
Phillip Koeffler, H | 1 |
Elstner, E | 1 |
1 other study available for pioglitazone and African Lymphoma
Article | Year |
---|---|
Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
Topics: Adolescent; Apoptosis; Blotting, Western; Burkitt Lymphoma; Cell Cycle; Cell Division; Cell Line, Tu | 2004 |